| Literature DB >> 33378991 |
Ran Wei1, Nannan Lai2, Lin Zhao1, Zhen Zhang1, Xiaoxiao Zhu1, Qiang Guo1, Chu Chu1, Xiaoxiao Fu1, Xia Li3.
Abstract
Dendritic cells (DCs) play a critical immuno-modulating role in pregnancy, which requires the maternal immune system to tolerate semiallogeneic fetus and at the same time to maintain adequate defense against pathogens. DCs interact closely with other immune components such as T cells, natural killer cells and macrophages, as well as the endocrine system to keep a pregnancy-friendly environment. Aberrant DC activities have been related to various pregnancy-associated diseases such as recurrent spontaneous abortion, preterm birth, pre-eclampsia, peripartum cardiomyopathy and infectious pregnancy complications. These findings make DCs an attractive candidate for prevention or therapy on the pregnancy-associated diseases. Here, we review recent findings that provide new insights into the roles of DCs in pregnancy and the related diseases. We also discuss the medical potentials to manipulate DCs in clinics. Whereas this is an emerging area with much work remaining, we anticipate that a better understanding of the role of DCs in maternal-fetal immunotolerance and a therapeutic manipulation of DCs will help women suffering from the pregnancy-associated diseases.Entities:
Keywords: Dendritic cells; Immunotolerance; Maternal-fetal interface; Pregnancy; Pregnancy-associated diseases
Mesh:
Year: 2020 PMID: 33378991 DOI: 10.1016/j.biopha.2020.110921
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529